Patients Digital skills: Why private clinics need effective communica... Recent studies have revealed that many UK families are unable to engage in today's digital society due to a lack of online
Digital Coming soon: New EU Artificial Intelligence Act Everyone is talking AI these days – and regulators are taking notice.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.